RAC 1.56% $1.58 race oncology ltd

Ann: Compelling Preclinical Breast Cancer Results, page-131

  1. 1,014 Posts.
    lightbulb Created with Sketch. 11287
    We are expecting the following by 31st of March:
    1. FTO preclinical activity
    2. George Clinical breast cancer trial review
    3. AML programs

    FTO preclinical activity should include the trial design for the melanoma and/or ccRCC preclinical FTO trials. Based on the announcement today, I am also expecting our first preclinical FTO results announcement describing the FTO expression in MCF-7 breast cancer cell lines. This will come under the FTO preclinical activity section.

    All IMO
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.